Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from NetScientific ( (GB:EMVC) ).
EMV Capital plc will host a virtual “Meet the Portfolio” event on 26 February 2026 to showcase two of its holdings, Vortex and DName-iT, to current and prospective investors. The session, delivered via the Investor Meet Company platform and led by CEO Ilian Iliev, is part of the group’s investor engagement strategy and is designed to provide deeper insight into its exposure to precision oncology and next-generation sequencing technologies.
Management from Vortex, a specialist in liquid biopsy technologies for precision oncology, and DName-iT, a MedTech firm using patented DNA barcoding for specimen labelling in next-generation sequencing, will present during the event. By highlighting these portfolio companies, EMV Capital is underscoring its focus on cutting-edge healthcare technologies and aiming to strengthen investor understanding of its portfolio composition and value-creation prospects, without disclosing any inside information under UK MAR.
The most recent analyst rating on (GB:EMVC) stock is a Hold with a £58.00 price target. To see the full list of analyst forecasts on NetScientific stock, see the GB:EMVC Stock Forecast page.
Spark’s Take on GB:EMVC Stock
According to Spark, TipRanks’ AI Analyst, GB:EMVC is a Neutral.
The overall stock score is primarily influenced by the company’s financial performance challenges, particularly in profitability and cash flow management. While technical indicators show bullish momentum, the valuation is unattractive due to negative earnings. Positive corporate events provide some optimism for future growth and strategic positioning.
To see Spark’s full report on GB:EMVC stock, click here.
More about NetScientific
EMV Capital plc is a London-headquartered venture capital investment group focused on deep tech and life sciences, backing early-stage, IP-rich companies in fast-growing sectors. The firm holds direct equity stakes and carried interest across an international portfolio, deploying capital via its balance sheet, managed funds and syndicated deals while actively supporting portfolio companies through board roles and value-creation services.
Average Trading Volume: 41,217
Technical Sentiment Signal: Buy
Current Market Cap: £15.66M
For detailed information about EMVC stock, go to TipRanks’ Stock Analysis page.